Archives

img-01

India Cracks Down on Drug GMP

The Indian drug business is a huge business estimated at about $67 billion per year. Many Western drug companies rely on Indian APIs, excipients, and final drug products. Last December, the Health Ministry required all Indian drug companies to meet Indian GMP... Read More

img-01

Quick Asian Regulatory Updates

On July 18, the Japanese Ministry of Health, Labor and Welfare (MHLW)  introduced new criteria for excluding certain drugs from mandatory post-marketing surveillance (PMS), traditionally required for newly approved medicines. This initiative aims to mitigate delays and reduce losses in drug availability. The MHLW informed... Read More

img-01

India Drug Regulations Update

With over 1.4 billion people, India is currently the 3rd largest market in Asia after China and Japan. With geo-political tensions mounting between the US and China, more Western drug companies are thinking about manufacturing and sourcing drugs and drug components from... Read More

img-01

India’s Medical Device Regulatory Update 2024

In recent months, India has made significant strides in reshaping the regulatory framework of its medical device industry. These initiatives are designed to improve the Indian medical device market and contain healthcare costs. Updates to Medical Device Licensing Requirements The Medical Device... Read More